Table 1.
Patients, tumor, and blood characteristics.
| Median (range) or n (%) | ||
|---|---|---|
| Age, years | 58 (36–84) | |
| Sex | Male | 34 (43) |
| Female | 45 (57) | |
| T-stage | T1 | 22 (28) |
| T2 | 35 (44) | |
| T3 | 16 (20) | |
| T4 | 6 (8) | |
| N-stage | N0 | 49 (62) |
| N1 | 30 (38) | |
| Grading | G1 | 4 (5) |
| G2 | 50 (63) | |
| G3 | 21 (27) | |
| Gx | 4 (5) | |
| Pretreatment blood counts | ||
| Leukocytes (/nl) | 7.69 (3.2–13.38) | |
| Platelets (/nl) | 266 (111–531) | |
| Hemoglobin (mg/dl) | 13.5 (10.2–16.2) | |
| Radiotherapy (RT) | ||
| RT modality | 3D conformal RT | 32 |
| Intensity-modulated-RT | 47 | |
| Total dose (Gy) | 59.4 (34.2–64.8) | |
| Boost dose (Gy) | 9 (0–19.8) |